Tech Company Financing Transactions
AAVantgarde Funding Round
AAVantgarde, operating out of Milano, scored $65.4 million from Atlas Venture, Forbion Capital Partners and Longwood Fund.
Transaction Overview
Company Name
Announced On
6/6/2023
Transaction Type
Venture Equity
Amount
$65,397,000
Round
Series A
Investors
Atlas Venture (Lead Investor)
Forbion Capital Partners (Lead Investor)
Proceeds Purpose
This financing will fund completion of a first-in-man proof of concept (POC) study in subjects with Usher1B and further development of AAV intein program and entry into the clinic for Stargardt disease. The company also intends to pursue programs beyond ophthalmology.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Via Vincenzo Gioberti, 8
Milano, 20123
iT
Milano, 20123
iT
Phone
Website
Email Address
Overview
AAVantgarde Bio is a clinical stage, Italian headquartered, international biotechnology company that has developed two proprietary Adeno-Associated Viral (AAV) vector platforms to address the gene therapy cargo capacity limitations of AAV vectors. This platform is being clinically validated in two Inherited Retinal Diseases; Usher1B and Stargardt disease, and the platform is expected to address the gene therapy cargo capacity limitations of AAV vectors and therefore the future pipeline could extend into many disease areas.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Natalia Misciattelli
Chief Medical Officer
Naveed Shams
Founder
Alberto Auricchio
Browse more venture capital transactions:
Prev: 6/6/2023: Ambr venture capital transaction
Next: 6/6/2023: Cargofive venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs